The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to use entecavir combined with other drug such as resveratrol
and thymosin to treat patients with hepatitis B, which may provide a novel therapy target
hepatitis B.
Phase:
N/A
Details
Lead Sponsor:
First Hospital of Jilin University The First Hospital of Jilin University